KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Inventory (2018 - 2025)

Historic Inventory for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $263.9 million.

  • BioNTech SE's Inventory fell 2073.32% to $263.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.9 million, marking a year-over-year decrease of 2073.32%. This contributed to the annual value of $302.7 million for FY2024, which is 2134.02% down from last year.
  • Latest data reveals that BioNTech SE reported Inventory of $263.9 million as of Q3 2025, which was down 2073.32% from $261.1 million recorded in Q2 2025.
  • BioNTech SE's Inventory's 5-year high stood at $574.8 million during Q4 2021, with a 5-year trough of $177.2 million in Q1 2021.
  • For the 5-year period, BioNTech SE's Inventory averaged around $373.9 million, with its median value being $375.2 million (2024).
  • As far as peak fluctuations go, BioNTech SE's Inventory skyrocketed by 65216.18% in 2021, and later crashed by 2869.8% in 2025.
  • Quarter analysis of 5 years shows BioNTech SE's Inventory stood at $574.8 million in 2021, then dropped by 21.98% to $448.5 million in 2022, then fell by 14.19% to $384.9 million in 2023, then dropped by 21.34% to $302.7 million in 2024, then dropped by 12.84% to $263.9 million in 2025.
  • Its last three reported values are $263.9 million in Q3 2025, $261.1 million for Q2 2025, and $267.6 million during Q1 2025.